Where did Anna French go to school?

Anna French studied at University of Oxford (PhD, Clinical and Laboratory Sciences); University of Bristol (BSc, Biochemistry).

Anna French

Director at Renasant Bio

Cambridge, Massachusetts, United States

Find your path to Anna

128 people in our graph can introduce you to Anna.

Paths you didn't know you had: your email and LinkedIn already hold routes to Anna. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Anna French, D.Phil., is Managing Partner at Qiming Venture Partners USA, which she joined in 2017 from the Boston Consulting Group, where she advised pharmaceutical and biotech companies on strategy and operations with a focus on cell therapy and regenerative medicine. She previously led the CASMI Translational Stem Cell Consortium, an industry-academic partnership between Oxford University and University College London focused on translating scientific innovation into the clinic. French holds a D.Phil. from the University of Oxford, where her research addressed the hematological differentiation of human induced pluripotent stem cells, and a BSc in Biochemistry from the University of Bristol; she has authored over 20 publications in stem cell research.

Experience

Qiming Venture Partners USAManaging Partnercurrent2017 — presentGreater Boston
Altis LabsBoard Directorcurrent2026 — presentToronto, Ontario, Canada
Renasant BioBoard Directorcurrent2025 — presentSan Francisco Bay Area
Montage BioBoard Directorcurrent2023 — presentNew York City Metropolitan Area
Empirico Inc.Board Directorcurrent2023 — presentSan Diego, California, United States
Entact BioBoard Directorcurrent2023 — presentBoston, Massachusetts, United States
Umoja BiopharmaBoard Directorcurrent2020 — presentSeattle, Washington, United States
Auron TherapeuticsBoard Directorcurrent2020 — presentBoston, Massachusetts, United States
Tenpoint Therapeutics LtdBoard Director2020 — 2024London Area, United Kingdom
Jasper TherapeuticsBoard Director2019 — 2024
WindMIL TherapeuticsBoard Director2018 — 2023Washington DC-Baltimore Area
Talaris TherapeuticsBoard Observer2018 — 2021
Cadent TherapeuticsBoard Observer2018 — 2021Cambridge, MA
LetsGetCheckedBoard Observer2018 — 2020New York City Metropolitan Area
The Boston Consulting GroupManagement Consultant2014 — 2017Boston, US / London, UK
Centre for the Advancement of Sustainable Medical Innovation (CASMI)Manager- CASMI Translational Stem Cell Consortium2012 — 2014Greater Oxford Area
University of OxfordGraduate Researcher2009 — 2013Greater Oxford Area

Skills & more

Science13Literature Reviews3Research25Statistics7Teaching6Molecular Biology21Qualitative Research3Flow Cytometry4Cell Biology6Biotechnology29Stem Cells12Biomedical Engineering3

+6 more

Clinical ResearchLifesciencesLife SciencesData AnalysisCell CultureManagement

From Anna's professional profile.

Frequently asked questions

Who is Anna French?: Anna French, D.Phil., is Managing Partner at Qiming Venture Partners USA, which she joined in 2017 from the Boston Consulting Group, where she advised pharmaceutical and biotech companies on strategy and operations with a focus on cell therapy and regenerative medicine. She previously led the CASMI Translational Stem Cell Consortium, an industry-academic partnership between Oxford University and University College London focused on translating scientific innovation into the clinic. French holds a D.Phil. from the University of Oxford, where her research addressed the hematological differentiation of human induced pluripotent stem cells, and a BSc in Biochemistry from the University of Bristol; she has authored over 20 publications in stem cell research.
Where did Anna French go to school?: Anna French studied at University of Oxford (PhD, Clinical and Laboratory Sciences); University of Bristol (BSc, Biochemistry).